Literature DB >> 5338565

Imipramine (Tofranil vs. placebo in hospitalized psychotic depressives. (a comparison of patients' self-ratings, psychiatrists' ratings and psychological test scores).

A S Friedman, S Granick, H W Cohen, B Cowitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5338565     DOI: 10.1016/0022-3956(66)90012-4

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


× No keyword cloud information.
  7 in total

1.  A comparison of antidepressant trials using active and inert placebos.

Authors:  Joanna Moncrieff
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

2.  The electroencephalographic and psychological effects of imipramine in depressed inpatients.

Authors:  S Bhanji; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

Review 3.  Effects of antidepressants on cognitive functioning of elderly patients. A review.

Authors:  H Knegtering; M Eijck; A Huijsman
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

4.  Drug-related test patterns of depressed patients.

Authors:  J F Legg; M P Stiff
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

5.  Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.

Authors:  B Spring; A J Gelenberg; R Garvin; S Thompson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Depressive illness in a general practice. A demographic study and a controlled trial of imipramine.

Authors:  A M Porter
Journal:  Br Med J       Date:  1970-03-28

Review 7.  Pharmacological treatment for psychotic depression.

Authors:  Jacolien Kruizinga; Edith Liemburg; Huibert Burger; Andrea Cipriani; John Geddes; Lindsay Robertson; Beatrix Vogelaar; Willem A Nolen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.